Citation Impact
Citing Papers
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer?
2009
Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer
2016
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: A cohort study
2010
Hepatocellular carcinoma
2003 Standout
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Inflammation and cancer
2002 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Molecular pathogenesis of human hepatocellular carcinoma
2002
Ulcerative Colitis
2011 Standout
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
2008 Standout
Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: A KASID study
2007
Clevudine: a potent inhibitor of hepatitis B virusin vitroandin vivo
2006
Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
2013
Hepatitis C viral protein translation: mechanisms and implications in developing antivirals
2011
Interaction between hepatitis C virus proteins and host cell factors
2002 StandoutNobel
The Reduction in Colorectal Cancer Mortality After Colonoscopy Varies by Site of the Cancer
2010
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks
2002
IgG4-Related Disease
2012 Standout
Analyzing real-time PCR data by the comparative CT method
2008 Standout
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
2004 Standout
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Autoimmune pancreatitis: Imaging features
2018
Risk of Developing Colorectal Cancer Following a Negative Colonoscopy Examination
2006
Colorectal cancer
2019 Standout
Effect of Screening Colonoscopy on Colorectal Cancer Incidence and Mortality
2009
Global cancer statistics
2011 Standout
Viral hepatitis and liver cancer: the case of hepatitis C
2006
Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation
2004
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
Recent Knowledge of the Relationship Between Helicobacter pylori and Gastric Cancer and Recent Progress of Gastroendoscopic Diagnosis and Treatment for Gastric Cancer
2010
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
2010
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels
2009
Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review
2009
Chronic hepatitis B
2007 Standout
Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro
2003
Chronic hepatitis B: Update 2009 #
2009 Standout
Viruses and tumours – an update
2004
HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis
2002
Inflammatory bowel disease in the Asia–Pacific area: A comparison with developed countries and regional differences
2010
Hepatitis C Virus Core Protein Acts as a trans-Modulating Factor on Internal Translation Initiation of the Viral RNA
2005
Hypersusceptibility to Vesicular Stomatitis Virus Infection in Dicer1-Deficient Mice Is Due to Impaired miR24 and miR93 Expression
2007 StandoutNobel
Microwave-activated nanodroplet vaporization for highly efficient tumor ablation with real-time monitoring performance
2016
Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase
2005 StandoutNatureNobel
TP53 and liver carcinogenesis
2003
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
2006 StandoutNature
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
The NS5A Protein of Hepatitis C Virus Is a Zinc Metalloprotein
2004 StandoutNobel
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
2014
The cancer genome
2009 StandoutNature
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
Hepatitis C Virus Core Protein Is a Potent Inhibitor of RNA Silencing-Based Antiviral Response
2006
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
2001 Standout
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Cytosol and nuclear receptors for 5α-dihydrotestosterone and testosterone in the hypothalamus and hypophysis, and testosterone receptors isolated from neonatal female rat hypothalamus
1976
Androgen receptors in the perinatal rat brain
1980
Hepatitis C virus non-structural protein NS4B can modulate an unfolded protein response.
2005
Androgen receptors exist throughout the ‘critical period’ of brain sexual differentiation
1979 Nature
Functional analysis of mutations within the kinase activation segment of B-Raf in human colorectal tumors.
2003
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
British Society of Gastroenterology position statement on serrated polyps in the colon and rectum
2017
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication
2007 StandoutNobel
Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B
2014 StandoutNobel
Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy inHelicobacter pylori-positive patients with gastric ulcers
2010
Nuclear Localization of Japanese Encephalitis Virus Core Protein Enhances Viral Replication
2005
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
2002
Inhibition of Hepatitis B Virus Polymerase by Entecavir
2007
Quantitation of Viral Load Using Real-Time Amplification Techniques
2001
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Hepatitis C Virus: Evading the Intracellular Innate Immunity
2020
Inflammatory Bowel Disease in the United States from 1998 to 2005: Has Infliximab Affected Surgical Rates?
2009
Evaluation of the in vitro anti-HBV activity of clevudine in combination with other nucleoside/ nucleotide inhibitors
2009
Global cancer statistics, 2012
2015 Standout
Sexual Differentiation of the Central Nervous System
1981 StandoutScience
Embryonic Rodent Brain Contains Estrogen Receptors
1979 Science
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Expression of vasopressin receptors in hamster hypothalamus is sexually dimorphic and dependent upon photoperiod.
1991 StandoutNobel
In Vitro Susceptibilities of Wild-Type or Drug-Resistant Hepatitis B Virus to (−)-β-d -2,6-Diaminopurine Dioxolane and 2′-Fluoro-5-Methyl-β-l -Arabinofuranosyluracil
2001
Works of Jun Kato being referenced
Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor α expression via activation of nuclear factor-κB
2006
Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer
2000
The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance
2001
Systematic Analysis of the TGF-β-Smad Signaling Pathway in Gastrointestinal Cancer Cells
2001
Assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma; comparison between magnetic resonance imaging with ferucarbotran and enhanced CT with iodized oil deposition
2011
Hepatitis C Virus Core Protein Activates Nuclear Factor κB-dependent Signaling through Tumor Necrosis Factor Receptor-associated Factor
2001
Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo
2001
Flat-Type Early Colorectal Cancer Preferentially Develops in Right-Sided Colon in Older Patients
2004
Interferons Specifically Suppress the Translation from the Internal Ribosome Entry Site of Hepatitis C Virus through a Double‐Stranded RNA–Activated Protein Kinase–Independent Pathway
2002
Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type
2007
Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000
2007
Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis
2011
The Presence of Large Serrated Polyps Increases Risk for Colorectal Cancer
2010
Hepatitis C Virus Core Protein Enhances p53 Function through Augmentation of DNA Binding Affinity and Transcriptional Ability
2000
A Comparison of the Immunochemical Fecal Occult Blood Test and Total Colonoscopy in the Asymptomatic Population
2005
ONTOGENY OF 5α-DIHYDROTESTOSTERONE RECEPTORS IN THE HYPOTHALAMUS OF THE RAT
1976
Contrast-Enhanced Endoscopic Ultrasonography for Pancreatic Tumors
2015
Slight Increases in the Disease Activity Index and Platelet Count Imply the Presence of Active Intestinal Lesions in C-reactive Protein-negative Crohn's Disease Patients
2014